Bleeding prophylaxis with efanesoctocog alfa also in…

medicine Friday, July 19, 2024 Milwaukee/Wisconsin The coagulation drug Efanesoctocog alfa, which was recently approved in Europe as Altuvoct, offers patients with hemophilia A the prospect of bleeding prophylaxis with just a once-weekly infusion. After